1.Clinical and Laboratory Standards Institute. Principle and Procedures for Blood Cultures; Approved Guideline. CLSI Document M47-A. Wayne, PA; Clinical and Laboratory Standards Institute. 2007.
2.Rosenblatt JE. Can we afford to do anaerobic cultures and identification? A positive point of view. Clin Infect Dis. 1997. 25(Suppl 2):S127–31.
Article
3.Iwata K., Takahashi M. Is anaerobic blood culture necessary? If so, who needs it? Am J Med Sci. 2008. 336:58–63.
Article
4.Grohs P., Mainardi JL., Podglajen I., Hanras X., Eckert C., Buu-Hoï A, et al. Relevance of routine use of the anaerobic blood culture bottle. J Clin Microbiol. 2007. 45:2711–5.
Article
5.Cornish N., Kirkley BA., Easley KA., Washington JA. Reassessment of the routine anaerobic culture and incubation time in the BacT/Alert FAN blood culture bottles. Diagn Microbiol Infect Dis. 1999. 35:93–9.
Article
6.Chandler MT., Morton ES., Byrd RP Jr., Fields C., Roy MT. Reevaluation of anaerobic blood cultures in a Veteran population. South Med J. 2000. 93:986–8.
Article
7.Fenner L., Widmer AF., Straub C., Frei R. Is the incidence of anaerobic bacteremia decreasing? Analysis of 114,000 blood cultures over a ten-year period. J Clin Microbiol. 2008. 46:2432–4.
Article
8.Gray JW., Pedler SJ. Low frequency of anaerobic bacteremia. Am J Med. 1992. 93:706–7.
Article
9.Ziegler R., Johnscher I., Martus P., Lenhardt D., Just HM. Controlled clinical laboratory comparison of two supplemented aerobic and anaerobic media used in automated blood culture systems to detect bloodstream infections. J Clin Microbiol. 1998. 36:657–61.
Article
10.Diekema DJ., Beekmann SE., Chapin KC., Morel KA., Munson E., Doern GV. Epidemiology and outcome of nosocomial and community-onset bloodstream infection. J Clin Microbiol. 2003. 41:3655–60.
Article
11.Martin GS., Mannino DM., Eaton S., Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003. 348:1546–54.
Article
12.Weinstein MP., Towns ML., Quartey SM., Mirrett S., Reimer LG., Parmigiani G, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis. 1997. 24:584–602.
Article
13.Kim NH., Hwang JH., Song KH., Choe PG., Park WB., Kim ES, et al. Changes in antimicrobial susceptibility of blood isolates in a university hospital in South Korea, 1998-2010. Infect Chemother. 2012. 44:275–81.
Article
14.Morris AJ., Wilson ML., Mirrett S., Reller LB. Rationale for selective use of anaerobic blood cultures. J Clin Microbiol. 1993. 31:2110–3.
Article
15.Brook I. The role of anaerobic bacteria in bacteremia. Anaerobe. 2010. 16:183–9.
Article
16.Park SH., Shim H., Yoon NS., Kim MN. Clinical relevance of time-to-positivity in BACTEC9240 blood culture system. Korean J Lab Med. 2010. 30:276–83.
Article
17.Shoji K., Komuro H., Watanabe Y., Miyairi I. The utility of anaerobic blood culture in detecting facultative anaerobic bacteremia in children. Diagn Microbiol Infect Dis. 2013. 76:409–12.
Article
18.Goldstein EJ. Anaerobic bacteremia. Clin Infect Dis. 1996. 23(Suppl 1):S97–101.
Article
19.Redondo MC., Arbo MD., Grindlinger J., Snydman DR. Attributable mortality of bacteremia associated with the Bacteroides fragilis$$$$.
20.Shin JH., Song SA., Kim MN., Kim S. Nationwide survey of blood culture performance regarding skin disinfection, blood collection and laboratory procedures. Korean J Clin Microbiol. 2011. 14:91–6.
Article
21.Redondo MC., Arbo MD., Grindlinger J., Snydman DR. Attributable mortality of bacteremia associated with the Bacteroides fragilis group. Clin Infect Dis. 1995. 20:1492–6.